A detailed history of Thomasville National Bank transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Thomasville National Bank holds 15,000 shares of AVXL stock, worth $138,150. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,000
Previous 16,250 7.69%
Holding current value
$138,150
Previous $92,000 75.0%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

SELL
$5.11 - $12.56 $6,387 - $15,700
-1,250 Reduced 7.69%
15,000 $161,000
Q4 2023

Jan 11, 2024

BUY
$5.04 - $9.95 $6,300 - $12,437
1,250 Added 8.33%
16,250 $151,000
Q2 2021

Jul 02, 2021

BUY
$10.16 - $28.86 $152,400 - $432,900
15,000 New
15,000 $343,000
Q1 2021

Apr 01, 2021

SELL
$5.17 - $16.13 $51,700 - $161,300
-10,000 Closed
0 $0
Q2 2020

Jul 01, 2020

BUY
$2.62 - $5.2 $26,200 - $52,000
10,000 New
10,000 $49,000

Others Institutions Holding AVXL

About ANAVEX LIFE SCIENCES CORP.


  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $718M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Thomasville National Bank Portfolio

Follow Thomasville National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thomasville National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Thomasville National Bank with notifications on news.